PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long term use of oral bisphosphonates may double risk of esophageal cancer

Research: Oral bisphosphonates and risk of cancer of the esophagus, stomach and colorectum: Case-control analysis within a UK primary care cohort

2010-09-04
(Press-News.org) People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.

Oral bisphosphonates are a type of drug used to treat osteoporosis and other bone diseases and are the most commonly recommended treatment for such conditions.

Case reports suggest an association between use of oral bisphosphonates for osteoporosis and increased risk of oesophageal cancer. But the evidence is limited, and no adequately large study with information on potential confounding factors and long follow-up has been published.

So researchers from the University of Oxford's Cancer Epidemiology Unit and the Medicines and Healthcare products Regulatory Agency carried out a large-scale study to look into the possibility of an association.

They analysed data from the UK General Practice Research Database, which has anonymised patient records for around six million people registered with a NHS GP.

They focused on men and women aged over 40 years - 2,954 with oesophageal cancer, 2,018 with stomach cancer and 10,641 with colorectal (bowel) cancer diagnosed between 1995 and 2005. Each case was compared with five controls matched for age, sex, general practice and observation period.

They found that people with 10 or more prescriptions, or with prescriptions over about five years, had nearly double the risk of oesophageal cancer compared with people with no bisphosphonate prescriptions.

There was no such increased risk for stomach or bowel cancer.

Typically, oesophageal cancer develops in one per 1000 people at age 60-79 over five years. Based on their findings, the authors estimate that with five years' use of oral bisphosphonates this would increase to two cases per 1000 people taking bisphosphonates over five years.

Although these results appear to contradict another recently published study using the same database, which reported no increased risk of oesophageal cancer with oral bisphosphonate use, today's report tracked patients for nearly twice as long, and also had greater statistical power.

The study's lead author, Dr Jane Green, says: "Oesophageal cancer is uncommon. The increased risks we found were in people who used oral bisphosphonates for about five years, and even if our results are confirmed, few people taking bisphosphonates are likely to develop oesophageal cancer as a result of taking these drugs. Our findings are part of a wider picture. Bisphosphonates are being increasingly prescribed to prevent fractures, and what is lacking is reliable information on the benefits and risks of their use in the long term."

In an accompanying editorial, Dr Diane Wysowski, an epidemiologist at the US Food and Drug Administration, discusses the differences between the two studies. She says that "the possibility of adverse effects on the oesophagus should prompt doctors who prescribe these drugs to consider risks versus benefits." She also suggests doctors "tell patients to report difficulty in swallowing and throat, chest, or digestive discomfort so that they can be promptly evaluated and possibly advised to discontinue the drug."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Roll-out of electronic patient records likely to be a long and complex process

2010-09-04
Interim results from the first comprehensive evaluation of the implementation of electronic health records in secondary care in England have found delays and frustration with the system, according to research published on bmj.com today. The authors, led by Professor Aziz Sheikh from The University of Edinburgh (and which included researchers from The London School of Economics and Political Science, The School of Pharmacy and The University of Nottingham), say experiences from the first-wave implementation site "indicate that delivering improved healthcare through nationwide ...

Scientists unwrap DNA packaging to gain insight into cells

2010-09-04
Scientists have built a clearer picture of how lengthy strands of DNA are concertinaed when our cells grow and divide, in a discovery could help explain how cell renewal can go wrong. Scientists have identified thousands of proteins that play a key role in compacting DNA – a crucial process by which DNA is shortened up to 10,000 times to fit inside cells as they split into two. Researchers hope the findings could shed light on what happens when this packaging process fails and cells divide abnormally – which can lead to cancer or cause developing embryos to miscarry. Scientists ...

Bochum's researchers discover proton diode

Bochums researchers discover proton diode
2010-09-04
Biophysicists in Bochum have discovered a diode for protons: just like the electronic component determines the direction of flow of electric current, the "proton diode" ensures that protons can only pass through a cell membrane in one direction. Water molecules play an important role here as active components of the diode. The researchers led by Prof. Dr. Klaus Gerwert (Chair of Biophysics at the RUB) were able to observe this through a combination of molecular biology, X-ray crystallography, time-resolved FTIR spectroscopy and biomolecular simulations. They report in the ...

Head start for migraine sufferers

2010-09-04
For severe migraine sufferers, psychological treatments build on the benefits of drug therapy, according to a new study1 by Elizabeth Seng and Dr. Kenneth Holroyd from Ohio University in the US. Their comparison of the effects of various treatment combinations for severe migraine – drug therapy with or without behavioral management – shows that those patients receiving the behavioral management program alongside drug therapy are significantly more confident in their ability to use behavioral skills to effectively self-manage migraines. And surprisingly, the increase in ...

Ancient brew masters tapped antibiotic secrets

2010-09-04
A chemical analysis of the bones of ancient Nubians shows that they were regularly consuming tetracycline, most likely in their beer. The finding is the strongest evidence yet that the art of making antibiotics, which officially dates to the discovery of penicillin in 1928, was common practice nearly 2,000 years ago. The research, led by Emory University anthropologist George Armelagos and medicinal chemist Mark Nelson of Paratek Pharmaceuticals, Inc., is in the current issue of the American Journal of Physical Anthropology. "We tend to associate drugs that cure diseases ...

Connection between light at night and cancer revealed in additional study

2010-09-04
A new study from the Center for Interdisciplinary Chronobiological Research at the University of Haifa has found an additional link between Light At Night (LAN) and cancer. This research joins a series of earlier studies carried out at the University of Haifa that also established the correlation. "High power light bulbs contribute more to 'environmental light pollution', which the study has shown is a carcinogenic pollution," notes Prof. Abraham Haim, who headed the study. Earlier studies in which Prof. Haim has participated at the University of Haifa, have shown that ...

Listening to ancient colors

2010-09-04
A team of McGill chemists have discovered that a technique known as photoacoustic infrared spectroscopy could be used to identify the composition of pigments used in art work that is decades or even centuries old. Pigments give artist's materials colour, and they emit sounds when light is shone on them. "The chemical composition of pigments is important to know, because it enables museums and restorers to know how the paints will react to sunlight and temperature changes," explained Dr. Ian Butler, lead researcher and professor at McGill's Department of Chemistry. Without ...

EMAS publishes position statements about the post-reproductive health of women

2010-09-04
Amsterdam, 2 September, 2010 - Elsevier announced today the publication of four important position statements from the European Menopause and Andropause Society (EMAS) in the journal Maturitas (http://www.maturitas.org/) on common management problems in the post-reproductive health of women. The statements cover the management of the menopause in the context of obesity, epilepsy, endometriosis and premature ovarian failure. Each statement has summary recommendations as a quick aid for the busy clinician. "The expanding ageing female population means that clinicians ...

New climate change mitigation schemes could benefit elites rather than the rural poor

2010-09-04
Oaxaca, Mexico (3 September 2010)—With governments across Latin America preparing to implement a new financial mechanism aimed at mitigating climate change by curbing carbon emissions from the destruction of tropical forests, experts gathering here today warned against a "one-size-fits-all" approach, calling instead for flexible, balanced solutions to the thorny dilemmas surrounding this new mechanism. Among the experts' chief worries is that the wealthy and powerful could capture many of the benefits, largely at the expense of rural communities, including indigenous groups. ...

Safety cultures in EMS agencies vary widely, Pitt study finds

2010-09-04
PITTSBURGH, Sept. 2 – A survey of emergency medical services (EMS) agencies from across the country found wide variation in perceptions of workplace safety culture—providing a tool that might point to potential patient safety threats, according to researchers at the University of Pittsburgh School of Medicine. The study, to be published in the October/December issue of Prehospital Emergency Care and now available online, analyzed survey results from 61 EMS agencies in the U.S. and Canada. Researchers adapted a survey used in other health care settings to measure paramedic ...

LAST 30 PRESS RELEASES:

Study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system

Long-sought structure of powerful anticancer natural product solved by integrated approach

World’s oldest lizard wins fossil fight

Simple secret to living a longer life

Same plant, different tactic: Habitat determines response to climate

Drinking plenty of water may actually be good for you

Men at high risk of cardiovascular disease face brain health decline 10 years earlier than women

Irregular sleep-wake cycle linked to heightened risk of major cardiovascular events

Depression can cause period pain, new study suggests

Wistar Institute scientists identify important factor in neural development

New imaging platform developed by Rice researchers revolutionizes 3D visualization of cellular structures

To catch financial rats, a better mousetrap

Mapping the world's climate danger zones

Emory heart team implants new blood-pumping device for first time in U.S.

Congenital heart defects caused by problems with placenta

Schlechter named Cancer Moonshot Scholar

Two-way water transfers can ensure reliability, save money for urban and agricultural users during drought in Western U.S., new study shows

New issue of advances in dental research explores the role of women in dental, clinical, and translational research

Team unlocks new insights on pulsar signals

Great apes visually track subject-object relationships like humans do

Recovery of testing for heart disease risk factors post-COVID remains patchy

Final data and undiscovered images from NASA’s NEOWISE

Nucleoporin93: A silent protector in vascular health

Can we avert the looming food crisis of climate change?

Alcohol use and antiobesity medication treatment

Study reveals cause of common cancer immunotherapy side effect

New era in amphibian biology

Harbor service, VAST Data provide boost for NCSA systems

New prognostic model enhances survival prediction in liver failure

China focuses on improving air quality via the coordinated control of fine particles and ozone

[Press-News.org] Long term use of oral bisphosphonates may double risk of esophageal cancer
Research: Oral bisphosphonates and risk of cancer of the esophagus, stomach and colorectum: Case-control analysis within a UK primary care cohort